Since 2007, we have set as a priority in our hospital the eradication of nosocomial infections. To this end, we have developed a set of best practices for prevention of ventilator associated pneumonia ...

PHOENIX -- Individualized short-course antibiotic treatment proved noninferior to usual long-course treatment for 60-day mortality and pneumonia recurrence in patients with ventilator-associated ...

PHOENIX -- Administering ceftriaxone prophylactically in the intensive care unit (ICU) reduced the risk of ventilator-associated pneumonia (VAP) among patients with an acute brain injury, a randomized ...

Please provide your email address to receive an email when new articles are posted on . Fewer early ventilator-associated pneumonia cases occurred among patients with brain injury receiving ...

Scientists have made a breakthrough which could help find new treatments for a deadly infection that can affect up to 40% of hospital patients using mechanical ventilators. Scientists at The ...

Background. Ventilator-associated pneumonia (VAP) is among the most important hospital-acquired infections in the intensive-care unit setting. However, clinical data regarding the epidemiology of VAP ...

Please provide your email address to receive an email when new articles are posted on . Ventilator-associated pneumonia occurred less frequently in patients who received inhaled amikacin vs. placebo.

Research published in JAMA shows ventilator-associated pneumonia rates have stayed steady since 2005, contradicting CDC data showing a decline in VAP rates. “VAP is not going away; it still affects ...

NICE has withdrawn technical patient safety solutions for ventilator-associated pneumonia in adults, because the recommended action in section 1.2 on administering oral chlorhexidine is no longer ...